Edwards Lifesciences Research and Development Expense Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.22  0.09  0.0787%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Research and Development Expense of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Research and Development Expense  10 Years Trend  
Slightly volatile
 Research and Development Expense 

Edwards Lifesciences Research and Development Expense Over Time

2015-12-31  383,100,000 
2016-12-31  443,300,000 
2017-12-31  434,947,368 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  263,737,281
Geometric Mean  228,180,558
Coefficient Of Variation  48.18
Mean Deviation  106,620,614
Median  291,300,000
Standard Deviation  127,072,150
Range  388,300,000
R Value  1
R Squared  0.99
Significance  0
Slope  35,075,248

Currently Trending

Sold over 500 shares of
1 hour ago ago
Traded for 5.74
Sold over 100 shares of
1 hour ago ago
Traded for 22.58
Sold few shares of
1 hour ago ago
Traded for 178.39